Influence of heart rate, preload, afterload, and inotropic state on myocardial ultrasonic backscatter.

  • K B Sagar
    Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.
  • L E Pelc
    Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.
  • T L Rhyne
    Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.
  • L S Wann
    Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.
  • D C Waltier
    Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.

書誌事項

公開日
1988-02
DOI
  • 10.1161/01.cir.77.2.478
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

説明

<jats:p>Ultrasonic backscatter is substantially modified by pathologic changes in myocardium. Influence of physiologic changes in heart rate, mean arterial pressure, preload, and inotropic state were studied in 17 anesthetized open-chest dogs. Heart rate was changed with atrial pacing/ULFS'49 (a selective bradycardiac agent). Mean arterial pressure was varied with aortic constriction/nitroprusside, preload was altered with nitroglycerin/volume infusion, and inotropic states were altered with dobutamine (10 microns/kg)/esmolol (100 microns/kg). IBR5, an optimum weighted frequency average (4 to 6.8 MHz) of the squared envelope of diffraction corrected for absolute backscatter, and the Fourier coefficient of amplitude modulation (FAM), an index of cardiac cycle-dependent variation, were measured from six sequential electrocardiographically gated intervals throughout the cardiac cycle. Heart rate, mean arterial pressure, preload, and inotropic state did not significantly affect IBR5. FAM increased from 3.5 +/- 0.3 dB (mean +/- SEM) to 7.0 +/- 0.4 dB (p less than .01) at a heart rate of 120 beats/min, and decreased to 3.9 +/- 0.4 at a heart rate of 160 beats/min. No change in FAM was noted with a rise (70 +/- 12 to 45 +/- 10 mmHg) in mean arterial pressure or preload (an increase or decrease in diastolic segment length of +/- 10% from the baseline). Dobutamine produced a significant increase in left ventricular dP/dt (2600 +/- 200 to 3475 +/- 275 mm Hg) and FAM (3.4 +/- 0.1 to 6.4; p less than .01). Esmolol significantly reduced left ventricular dP/dt (2600 +/- 200 to 2000 +/- 175 mm Hg, p less than .05) and FAM (3.4 +/- 0.01 to 6.4 +/- 0.1; p less than .01). We conclude that IBR5 is independent of heart rate, mean arterial pressure, preload, and inotropic state. Cardiac cycle-dependent amplitude modulation follows changes in cardiac contraction.</jats:p>

収録刊行物

  • Circulation

    Circulation 77 (2), 478-483, 1988-02

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ